RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
-9.89%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$1.32B
AUM Growth
+$1.32B
(+8.2%)
Cap. Flow
+$214M
Cap. Flow
% of AUM
16.24%
Top 10 Holdings %
Top 10 Hldgs %
52.92%
Holding
77
New
22
Increased
20
Reduced
12
Closed
19
Top Buys
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$74.5M |
| 2 |
Penumbra
PEN
|
$51M |
| 3 |
Incyte
INCY
|
$49.5M |
| 4 |
RAD
Rite Aid Corporation
RAD
|
$49M |
| 5 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$44.3M |
Top Sells
| 1 |
Bausch Health
BHC
|
$85.4M |
| 2 |
AGN
Allergan plc
AGN
|
$41.5M |
| 3 |
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
|
$36.3M |
| 4 |
HCA Healthcare
HCA
|
$35.4M |
| 5 |
AbbVie
ABBV
|
$34.3M |
Sector Composition
| 1 | Healthcare | 77.44% |
| 2 | Communication Services | 1.09% |
| 3 | Industrials | 1% |
| 4 | Technology | 0.23% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXFD
26
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $13.9M | 1.05% |
1,028,132
-184,760
| -15% | -$2.49M |
|
|
CFMS
27
DELISTED
Conformis, Inc. Common Stock
CFMS
| $12.4M | 0.94% |
+688,845
| New | +$12.4M |
|
|
GBT
28
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $11.1M | 0.84% |
+262,892
| New | +$11.1M |
|
29
Fate Therapeutics
FATE
$115M
| $11.1M | 0.84% |
2,074,836
+67,390
| +3% | +$359K |
|
|
HNT
30
DELISTED
HEALTH NET INC
HNT
| $10.8M | 0.82% |
179,229
-208,899
| -54% | -$12.6M |
|
31
TriNet
TNET
$3.46B
| $10.7M | 0.81% |
+639,186
| New | +$10.7M |
|
|
CASC
32
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $9.91M | 0.75% |
3,614,990
-549,888
| -13% | -$1.51M |
|
33
ProQR Therapeutics
PRQR
$256M
| $9.63M | 0.73% |
660,816
+144,126
| +28% | +$2.1M |
|
|
BPMC
34
DELISTED
Blueprint Medicines
BPMC
| $7.84M | 0.59% |
367,485
-10,750
| -3% | -$229K |
|
|
TRIV
35
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
| $7.32M | 0.55% |
1,463,983
-580
| -0% | -$2.9K |
|
36
Cerus
CERS
$251M
| $7.28M | 0.55% |
1,603,427
| – | – |
|
37
Neurogene
NGNE
$284M
| $7.24M | 0.55% |
+514,300
| New | +$7.24M |
|
38
Adverum Biotechnologies
ADVM
$68.2M
| $6.17M | 0.47% |
748,420
+211,138
| +39% | +$1.74M |
|
39
Regenxbio
RGNX
$498M
| $6.1M | 0.46% |
+277,000
| New | +$6.1M |
|
40
DURECT Corp
DRRX
$60.2M
| $5.1M | 0.39% |
+2,613,316
| New | +$5.1M |
|
|
INFI
41
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $4.99M | 0.38% |
+590,100
| New | +$4.99M |
|
|
NVTA
42
DELISTED
Invitae Corporation
NVTA
| $4.77M | 0.36% |
660,129
+478,905
| +264% | +$3.46M |
|
|
CSLT
43
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $3.08M | 0.23% |
734,397
-1,250,234
| -63% | -$5.25M |
|
|
CCXI
44
DELISTED
ChemoCentryx, Inc.
CCXI
| $3.03M | 0.23% |
500,615
+24,322
| +5% | +$147K |
|
|
PGND
45
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
| $2.51M | 0.19% |
+84,966
| New | +$2.51M |
|
46
Carisma Therapeutics
CARM
$15.5M
| $2.05M | 0.15% |
848,351
-412,909
| -33% | -$995K |
|
47
Ironwood Pharmaceuticals
IRWD
$201M
| $1.99M | 0.15% |
+190,789
| New | +$1.99M |
|
|
NVRO
48
DELISTED
NEVRO CORP.
NVRO
| $1.16M | 0.09% |
+25,000
| New | +$1.16M |
|
|
GNCA
49
DELISTED
Genocea Biosciences, Inc.
GNCA
| $628K | 0.05% |
91,644
-531,875
| -85% | -$3.64M |
|
50
SPDR S&P Biotech ETF
XBI
$5.29B
| $576K | 0.04% |
+9,250
| New | +$576K |
|